Imatinib (trade name Gleevec) preserves fertility in female mice treated with the common chemotherapeutic agent cisplatin. Imatinib seems to block an apoptotic pathway activated by cisplatin in ovarian germ cells (pages 1179-1185). The findings could lead to new ways to protect germ cells from the damaging effects of cancer treatment.

Original languageEnglish (US)
Pages (from-to)1124-1125
Number of pages2
JournalNature Medicine
Issue number10
StatePublished - 2009

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'Preserving fertility during cancer treatment'. Together they form a unique fingerprint.

Cite this